Scopa James Paul — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Scopa James Paul has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
James Paul Scopa is an individual listed in SEC filings connected to Aligos Therapeutics, Inc. as of June 29, 2026. The provided context does not specify his exact role (e.g., officer, director, or other insider position) or his occupational history. Aligos Therapeutics is a biotechnology company focused on antiviral therapies. Because the context is limited to the company name in SEC filings, additional publicly available sources such as the company's leadership page, Form 4/13D filings, or press releases would be needed to confirm his current title and background.
Role
Insider
Notability
20/100
Board memberships
Aligos Therapeutics, Inc.
Awards & honors
Listed in SEC filings related to Aligos Therapeutics, Inc. as of 2026-06-29
James Paul Scopa is an individual listed in SEC filings connected to Aligos Therapeutics, Inc. as of June 29, 2026. The provided context does not specify his exact role (e.g., officer, director, or other insider position) or his occupational history. Aligos Therapeutics is a biotechnology company focused on antiviral therapies. Because the context is limited to the company name…
How many SEC Form 4 filings has Scopa James Paul submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Scopa James Paul's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
